-
-
-
-
-
-
-
Carisma Therapeutics and OrthoCellix Enter into Definitive Merger Agreement to Create Company Focused on Regenerative Cell Therapies for Orthopedic Diseases
-
-
-
-
-
-
-
Carmila: Closing of the Acquisition of a Stake of 7% of Galimmo SCA from Capimmo
-
-
-
-
-
-
-
Carmila: First-quarter 2024 Financial Information
-
-
-
-
-
-
-
Carmila: Agreement to acquire Galimmo SCA
-
-
-
-
-
-
-
Sesen Bio (SESN) and Carisma Therapeutics Announce Merger Agreement
-
-
-
-
-
-
-
Carmila: 2019 Annual Results
-
-
-
-
-
-
-
Carmila: 2018 Half-Year Results
-
1,154,876 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

